Epoetin theta

Epoetin theta is a type of erythropoiesis-stimulating agent (ESA) that is used to treat anemia associated with chronic kidney disease and chemotherapy. It is a recombinant form of human erythropoietin, a hormone produced by the kidneys to stimulate the production of red blood cells.

Etymology

The term "epoetin" is derived from the Greek words "epo" meaning "upon" and "poiesis" meaning "making". "Theta" is the eighth letter of the Greek alphabet and is used in the pharmaceutical industry to denote the eighth version of a drug.

Mechanism of Action

Epoetin theta works by stimulating the bone marrow to produce more red blood cells, thereby increasing the oxygen-carrying capacity of the blood. This can help to alleviate the symptoms of anemia, such as fatigue and weakness.

Side Effects

Like all medications, epoetin theta can cause side effects. These may include headache, nausea, vomiting, and high blood pressure. In rare cases, it can cause serious side effects such as blood clots and heart attacks.

Related Terms

• Erythropoiesis-stimulating agent
• Anemia
• Chronic kidney disease
• Chemotherapy
• Erythropoietin

See Also

• Epoetin alfa
• Epoetin beta
• Darbepoetin alfa

References

Epoetin theta Resources
Latest articles Most recent articles Ongoing trials	Wikipedia